Frontlight ResearchEarly access
Trial site
West China Hospital,Sichuan University
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Hearing loss1 trial
- Lupus (SLE)1 trial
- Triple-negative breast cancer1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- West China Hospital3 trials
- Abivax S.A.1 trial
- Chinese Academy of Medical Sciences1 trial
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
- Shanghai Junshi Bioscience Co., Ltd.1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
Recruiting
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Recruiting
Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Hearing loss1 recruiting
- Lung cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026